ArticleJournal of cellular and molecular medicine2013

Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms.

Niccolò Bartalucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.